1h Free Analyst Time
The publisher has been monitoring the atherosclerosis therapeutics market and it is poised to grow by $3.44 bn during 2022-2026 progressing at a CAGR of 5.66% during the forecast period. The report on the atherosclerosis therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing risk factors for atherosclerosis, the availability of advanced diagnostic methods, and the rising prevalence of hypercholesterolemia.
The atherosclerosis therapeutics market analysis includes the product segment and geographic landscape.
The atherosclerosis therapeutics market is segmented as below:
By Product
- Small molecules
- Biologics
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the identification of new pathogenic targets as one of the prime reasons driving the atherosclerosis therapeutics market growth during the next few years. Also, identification of new drug targets for atherosclerosis and strong incidence of coronary heart disease (CHD) will lead to sizable demand in the market.
The report on atherosclerosis therapeutics market covers the following areas:
- Atherosclerosis therapeutics market sizing
- Atherosclerosis therapeutics market forecast
- Atherosclerosis therapeutics market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading atherosclerosis therapeutics market vendors that include Amgen Inc., AstraZeneca Plc, Dr. Reddys Laboratories Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Ionis Pharmaceuticals Inc., Merck and Co. Inc., Novartis AG, Regeneron Pharmaceuticals Inc., Sanofi SA, Viatris Inc., GlaxoSmithKline Plc, and Pfizer Inc. Also, the atherosclerosis therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Product
5.1 Market segments
Exhibit 24: Chart on Product - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
5.2 Comparison by Product
Exhibit 26: Chart on Comparison by Product
Exhibit 27: Data Table on Comparison by Product
5.3 Small molecules - Market size and forecast 2021-2026
Exhibit 28: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
5.4 Biologics - Market size and forecast 2021-2026
Exhibit 32: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Biologics - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Product
Exhibit 36: Market opportunity by Product ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Canada - Market size and forecast 2021-2026
Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 Germany - Market size and forecast 2021-2026
Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Amgen Inc.
Exhibit 85: Amgen Inc. - Overview
Exhibit 86: Amgen Inc. - Product / Service
Exhibit 87: Amgen Inc. - Key offerings
10.4 AstraZeneca Plc
Exhibit 88: AstraZeneca Plc - Overview
Exhibit 89: AstraZeneca Plc - Product / Service
Exhibit 90: AstraZeneca Plc - Key news
Exhibit 91: AstraZeneca Plc - Key offerings
10.5 Dr. Reddys Laboratories Ltd.
Exhibit 92: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 93: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 94: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 95: Dr. Reddys Laboratories Ltd. - Segment focus
10.6 Eli Lilly and Co.
Exhibit 96: Eli Lilly and Co. - Overview
Exhibit 97: Eli Lilly and Co. - Product / Service
Exhibit 98: Eli Lilly and Co. - Key offerings
10.7 GlaxoSmithKline Plc
Exhibit 99: GlaxoSmithKline Plc - Overview
Exhibit 100: GlaxoSmithKline Plc - Business segments
Exhibit 101: GlaxoSmithKline Plc - Key news
Exhibit 102: GlaxoSmithKline Plc - Key offerings
Exhibit 103: GlaxoSmithKline Plc - Segment focus
10.8 Merck and Co. Inc.
Exhibit 104: Merck and Co. Inc. - Overview
Exhibit 105: Merck and Co. Inc. - Business segments
Exhibit 106: Merck and Co. Inc. - Key news
Exhibit 107: Merck and Co. Inc. - Key offerings
Exhibit 108: Merck and Co. Inc. - Segment focus
10.9 Novartis AG
Exhibit 109: Novartis AG - Overview
Exhibit 110: Novartis AG - Business segments
Exhibit 111: Novartis AG - Key offerings
Exhibit 112: Novartis AG - Segment focus
10.10 Pfizer Inc.
Exhibit 113: Pfizer Inc. - Overview
Exhibit 114: Pfizer Inc. - Product / Service
Exhibit 115: Pfizer Inc. - Key news
Exhibit 116: Pfizer Inc. - Key offerings
10.11 Sanofi SA
Exhibit 117: Sanofi SA - Overview
Exhibit 118: Sanofi SA - Business segments
Exhibit 119: Sanofi SA - Key news
Exhibit 120: Sanofi SA - Key offerings
Exhibit 121: Sanofi SA - Segment focus
10.12 Viatris Inc.
Exhibit 122: Viatris Inc. - Overview
Exhibit 123: Viatris Inc. - Business segments
Exhibit 124: Viatris Inc. - Key offerings
Exhibit 125: Viatris Inc. - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 126: Inclusions checklist
Exhibit 127: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 128: Currency conversion rates for US$
11.4 Research methodology
Exhibit 129: Research methodology
Exhibit 130: Validation techniques employed for market sizing
Exhibit 131: Information sources
11.5 List of abbreviations
Exhibit 132: List of abbreviations
List of ExhibitsExhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Product - Market share 2021-2026 (%)
Exhibits 25: Data Table on Product - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Product
Exhibits 27: Data Table on Comparison by Product
Exhibits 28: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Biologics - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
Exhibits 36: Market opportunity by Product ($ million)
Exhibits 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 40: Chart on Geographic comparison
Exhibits 41: Data Table on Geographic comparison
Exhibits 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 78: Market opportunity By Geographical Landscape ($ million)
Exhibits 79: Impact of drivers and challenges in 2021 and 2026
Exhibits 80: Overview on Criticality of inputs and Factors of differentiation
Exhibits 81: Overview on factors of disruption
Exhibits 82: Impact of key risks on business
Exhibits 83: Vendors covered
Exhibits 84: Matrix on vendor position and classification
Exhibits 85: Amgen Inc. - Overview
Exhibits 86: Amgen Inc. - Product / Service
Exhibits 87: Amgen Inc. - Key offerings
Exhibits 88: AstraZeneca Plc - Overview
Exhibits 89: AstraZeneca Plc - Product / Service
Exhibits 90: AstraZeneca Plc - Key news
Exhibits 91: AstraZeneca Plc - Key offerings
Exhibits 92: Dr. Reddys Laboratories Ltd. - Overview
Exhibits 93: Dr. Reddys Laboratories Ltd. - Business segments
Exhibits 94: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibits 95: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibits 96: Eli Lilly and Co. - Overview
Exhibits 97: Eli Lilly and Co. - Product / Service
Exhibits 98: Eli Lilly and Co. - Key offerings
Exhibits 99: GlaxoSmithKline Plc - Overview
Exhibits 100: GlaxoSmithKline Plc - Business segments
Exhibits 101: GlaxoSmithKline Plc - Key news
Exhibits 102: GlaxoSmithKline Plc - Key offerings
Exhibits 103: GlaxoSmithKline Plc - Segment focus
Exhibits 104: Merck and Co. Inc. - Overview
Exhibits 105: Merck and Co. Inc. - Business segments
Exhibits 106: Merck and Co. Inc. - Key news
Exhibits 107: Merck and Co. Inc. - Key offerings
Exhibits 108: Merck and Co. Inc. - Segment focus
Exhibits 109: Novartis AG - Overview
Exhibits 110: Novartis AG - Business segments
Exhibits 111: Novartis AG - Key offerings
Exhibits 112: Novartis AG - Segment focus
Exhibits 113: Pfizer Inc. - Overview
Exhibits 114: Pfizer Inc. - Product / Service
Exhibits 115: Pfizer Inc. - Key news
Exhibits 116: Pfizer Inc. - Key offerings
Exhibits 117: Sanofi SA - Overview
Exhibits 118: Sanofi SA - Business segments
Exhibits 119: Sanofi SA - Key news
Exhibits 120: Sanofi SA - Key offerings
Exhibits 121: Sanofi SA - Segment focus
Exhibits 122: Viatris Inc. - Overview
Exhibits 123: Viatris Inc. - Business segments
Exhibits 124: Viatris Inc. - Key offerings
Exhibits 125: Viatris Inc. - Segment focus
Exhibits 126: Inclusions checklist
Exhibits 127: Exclusions checklist
Exhibits 128: Currency conversion rates for US$
Exhibits 129: Research methodology
Exhibits 130: Validation techniques employed for market sizing
Exhibits 131: Information sources
Exhibits 132: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global atherosclerosis therapeutics market: Amgen Inc., AstraZeneca Plc, Dr. Reddys Laboratories Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Ionis Pharmaceuticals Inc., Merck and Co. Inc., Novartis AG, Regeneron Pharmaceuticals Inc., Sanofi SA, Viatris Inc., GlaxoSmithKline Plc, and Pfizer Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is identification of new pathogenic targets.`
According to the report, one of the major drivers for this market is the increasing risk factors for atherosclerosis.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amgen Inc.
- AstraZeneca Plc
- Dr. Reddys Laboratories Ltd.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- Ionis Pharmaceuticals Inc.
- Merck and Co. Inc.
- Novartis AG
- Regeneron Pharmaceuticals Inc.
- Sanofi SA
- Viatris Inc.
- GlaxoSmithKline Plc
- Pfizer Inc.
